Cancer risk in Swedish women: the relation to size at birth

British Journal of Cancer
S W AnderssonL Hulthén

Abstract

The relationship between fetal growth as indicated by weight and length at birth, and cancer risk in 1080 adult Swedish women was examined. Birth factors were retrieved from original midwife records for the years 1914, 1918, 1922 and 1930, and primary cancer cases were identified by matching with national and regional cancer registries through the year 1998. A positive and statistically significant increased risk for cancer was found with increasing birth weight or birth length for all site cancer and non-hormone related cancer, defined as all cancer sites excluding breast, uterus and ovary. Addition of factors suspected to influence cancer risk, maternal proteinuria, birth order, own parity and age at menarche, did not attenuate this relation. Previously only breast cancer has been reported to be related to size at birth in adult women and this is the first study to report that cancer sites other than the major hormone-related sites may be influenced by size at birth, as measured by either weight or length at birth; these findings warrant further investigation.

Citations

Jul 28, 2009·Journal of Women's Health·Xiaohui XuJeffrey Roth
Jan 22, 2008·Breast Cancer Research : BCR·Sue Kyung ParkLouise A Brinton
Oct 3, 2008·PLoS Medicine·Isabel dos Santos SilvaUNKNOWN Collaborative Group on Pre-Natal Risk Factors and Subsequent Risk of Breast Cancer
Dec 17, 2008·The British Journal of Nutrition·Graham C BurdgeAlan A Jackson
Jun 28, 2011·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Frank A Simmen, Rosalia C M Simmen
Apr 26, 2003·International Journal of Epidemiology·Mona Okasha
Oct 3, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M AhlgrenT I A Sørensen
Oct 16, 2004·The New England Journal of Medicine·Martin AhlgrenThorkild I A Sørensen
Apr 21, 2007·Journal of Internal Medicine·I Koupil
Dec 24, 2005·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Pagona LagiouDimitrios Trichopoulos
Nov 6, 2003·International Journal of Cancer. Journal International Du Cancer·Martin AhlgrenMads Melbye
Dec 6, 2006·British Journal of Cancer·M LöfE Weiderpass
Dec 19, 2007·British Journal of Cancer·I Franco-LieM Abdelnoor
Jun 29, 2006·International Journal of Cancer. Journal International Du Cancer·Sue Kyung ParkLouise A Brinton
Jul 11, 2006·International Journal of Cancer. Journal International Du Cancer·Karin B Michels, Fei Xue
Sep 14, 2006·European Journal of Epidemiology·Tom GrotmolSteinar Tretli
Aug 26, 2003·Expert Review of Anticancer Therapy·Annie J SascoRuth E Little
Feb 9, 2005·International Journal of Cancer. Journal International Du Cancer·Valerie A McCormackHans O Lithell
Jun 1, 2007·Cancer·Martin AhlgrenMads Melbye
Apr 28, 2006·British Journal of Cancer·R TroisiR N Hoover
Dec 27, 2005·American Journal of Human Biology : the Official Journal of the Human Biology Council·Grazyna JasienskaPeter T Ellison
Jul 23, 2011·Cancer Causes & Control : CCC·Susan HurleyPeggy Reynolds
May 3, 2003·Breast Cancer Research and Treatment·Mona OkashaGeorge Davey Smith
Nov 28, 2015·Digestive Diseases and Sciences·Seiji ShiotaAaron P Thrift
Jan 9, 2007·The American Journal of Clinical Nutrition·Kenneth J EllisWilliam C Heird
May 19, 2005·International Journal of Cancer. Journal International Du Cancer·Pagona LagiouDimitrios Trichopoulos

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.